Candinas D et al. |
Efficacy of leflunomide in combination with current immunosuppressive agents in rat cardiac allotransplantation. |
1994 |
Transplant. Proc. |
pmid:7527959
|
Tanabe K et al. |
Japanese single-center experience of kidney transplantation under tacrolimus immunosuppression. |
2000 |
Transplant. Proc. |
pmid:11119897
|
Alessiani M et al. |
Adverse effects of FK 506 overdosage after liver transplantation. |
1993 |
Transplant. Proc. |
pmid:7679825
|
Nishikawa K et al. |
Experimental studies of vascularized joint allografts in rats. |
1994 |
Transplant. Proc. |
pmid:7513482
|
Lye WC |
Primary tacrolimus-based immunosuppression in renal allograft recipients: a single center experience. |
2000 |
Transplant. Proc. |
pmid:11119898
|
Kobayashi M et al. |
FK 506 assay past and present--characteristics of FK 506 ELISA. |
1991 |
Transplant. Proc. |
pmid:1721258
|
Bechstein WO et al. |
Tacrolimus (FK 506) therapy is associated with a significant reduction in immunosuppressive treatment failures following primary liver transplantation. |
1996 |
Transplant. Proc. |
pmid:8623211
|
Aktürk S et al. |
Pregnancy After Kidney Transplantation: Outcomes, Tacrolimus Doses, and Trough Levels. |
2015 |
Transplant. Proc. |
pmid:26093738
|
Shoji T et al. |
Long-term acceptance of porcine pulmonary allografts without chronic rejection. |
2005 Jan-Feb |
Transplant. Proc. |
pmid:15808551
|
Ben-Ari Z et al. |
Comparison of tacrolimus with cyclosporin as primary immunosuppression in patients with hepatitis C virus infection after liver transplantation. |
2003 |
Transplant. Proc. |
pmid:12644067
|
Lladó L et al. |
Prospective evaluation of a quadruple therapy based on tacrolimus after liver transplantation. |
2002 |
Transplant. Proc. |
pmid:11959210
|
Taibi A et al. |
Rescue FK506 therapy for acute rejection and early chronic rejection after liver transplantation: report of 14 cases. |
1998 |
Transplant. Proc. |
pmid:9636571
|
Qu W et al. |
Correlation Between Immunosuppressive Therapy and CD4(+) T-Cell Intracellular Adenosine Triphosphate Levels in Liver Transplant Recipients. |
|
Transplant. Proc. |
pmid:27569951
|
Francavilla A et al. |
FK 506 as a growth control factor. |
1990 |
Transplant. Proc. |
pmid:1689912
|
Mazzaferro V et al. |
Studies of the hepatotrophic qualities of FK 506 and CyA. |
1990 |
Transplant. Proc. |
pmid:1689913
|
Ali MN et al. |
Case series: hemolytic uremic syndrome--another cause of transplant dysfunction. |
2013 |
Transplant. Proc. |
pmid:24182801
|
Oishi M et al. |
A case of hyperkalemic distal renal tubular acidosis secondary to tacrolimus in living donor liver transplantation. |
2000 |
Transplant. Proc. |
pmid:11120143
|
Gonzalez-Molina M et al. |
Mycophenolate mofetil and tacrolimus reduce mortality after deceased donor kidney transplantation. |
2012 |
Transplant. Proc. |
pmid:23146459
|
Batista F et al. |
Long-term follow-up after conversion from tacrolimus to cyclosporin in renal transplant patients with new-onset diabetes mellitus after transplantation. |
2012 |
Transplant. Proc. |
pmid:23146461
|
Soriano S et al. |
Single-center experience with initial intravenous dosing of tacrolimus after kidney transplantation. |
1999 |
Transplant. Proc. |
pmid:10576045
|
Yeung S et al. |
Primary immunosuppression with tacrolimus and low-dose mycophenolate mofetil in renal transplant recipients. |
2004 |
Transplant. Proc. |
pmid:15518754
|
McCauley J et al. |
Cyclosporine and FK 506 induced inhibition of renal epithelial cell proliferation. |
1991 |
Transplant. Proc. |
pmid:1721290
|
Hu RH et al. |
Effects of and predictors for tacrolimus rescue therapy among renal transplant patients under cyclosporine-based immunosuppression. |
2004 |
Transplant. Proc. |
pmid:15518757
|
Ciancio G et al. |
Human donor bone marrow cells can enhance hyporeactivity in renal transplantation using maintenance FK 506 and OKT3 induction therapy. |
1996 |
Transplant. Proc. |
pmid:8623473
|
Stratta RJ |
Late acute rejection episodes after vascularized pancreas transplantation. |
1998 |
Transplant. Proc. |
pmid:9636633
|
Zhao J et al. |
Diabetes mellitus after living donor liver transplantation: data from mainland China. |
2009 |
Transplant. Proc. |
pmid:19545722
|
Propper DJ et al. |
Low-dose FK 506 inhibits sensitisation after blood transfusions. |
1990 |
Transplant. Proc. |
pmid:1697114
|
Demirbas A et al. |
FK 506 in simultaneous pancreas/kidney transplantation: the University of Miami experience. |
1997 |
Transplant. Proc. |
pmid:9365608
|
Curro G et al. |
Transient ischemic attack after rizatriptan administration in a liver transplant recipient: a case report. |
2006 |
Transplant. Proc. |
pmid:17112920
|
Kliem V et al. |
Long-term results after primary successful FK 506 treatment of steroid- and OKT3-resistant rejection in renal transplant recipients. |
1997 |
Transplant. Proc. |
pmid:9365627
|
Murase N et al. |
Small bowel transplantation in sensitized recipients: comparison with heart, kidney, and liver grafts. |
1994 |
Transplant. Proc. |
pmid:7518139
|
Fujisaki S et al. |
Effects of preformed antibodies induced by whole blood transfusion on small bowel transplantation. |
1994 |
Transplant. Proc. |
pmid:7518140
|
Teisseyre J et al. |
Elevated tacrolimus levels during diarrhea in children after liver transplantation. |
2003 |
Transplant. Proc. |
pmid:14529919
|
Yu Y et al. |
Mutagenicity of the new immunosuppressive drugs, FK 506, and spergualin. |
1993 |
Transplant. Proc. |
pmid:7682364
|
Gaweco AS et al. |
Common and sequential overexpression patterns of T-helper cytokines during acute (cellular) rejection, and correlation of proinflammatory cytokine expression with chronic (ductopenic) rejection of human liver allografts: a study under cyclosporine, FK 506, and quadruple BT 563 immunosuppression. |
1995 |
Transplant. Proc. |
pmid:7533370
|
Kato T et al. |
FK506 may suppress liver injury during the early period following living-related liver transplantation. |
2003 |
Transplant. Proc. |
pmid:12591316
|
Tze WJ et al. |
FK 506--an effective immunosuppressant in achieving long-term functional islet allograft survival in diabetic rats. |
1992 |
Transplant. Proc. |
pmid:1376509
|
Rao PN et al. |
Prediction of early graft function by effluent levels of hyaluronic acid in clinical liver transplantation. |
1993 |
Transplant. Proc. |
pmid:7682366
|
Armstrong VW et al. |
Metabolic liver function and lipoprotein metabolism after orthotopic liver transplantation in patients on immunosuppressive therapy with FK 506 or cyclosporine. |
1995 |
Transplant. Proc. |
pmid:7533371
|
Takaori K et al. |
Effects of FK 506 on in vivo immunity in comparison to cyclosporine. |
1991 |
Transplant. Proc. |
pmid:1721322
|
Wasilewski G et al. |
Inadequate blood pressure control in orthotopic heart transplant: is there a role of kidney function and immunosuppressive regimen? |
2014 |
Transplant. Proc. |
pmid:25380929
|
Jordan ML et al. |
Inhibition of T-cell function by FK 506 and cyclosporine is not accompanied by alterations in intracellular calcium. |
1991 |
Transplant. Proc. |
pmid:1721323
|
Chung YW et al. |
Transcriptional activation of nuclear-related factor 2 by FK506 in Jurkat T cells. |
2015 |
Transplant. Proc. |
pmid:25891728
|
Benedini S et al. |
Glucose and leucine metabolism in lung tranplanted patients on low dose of steroids for immunosuppressive therapy. |
2008 |
Transplant. Proc. |
pmid:18589153
|
Waller JR et al. |
Effect of rapamycin in combination with calcineurin inhibitors, FK506 and cyclosporin, following arterial injury. |
2002 |
Transplant. Proc. |
pmid:12176449
|
Esposito C et al. |
Effect of calcineurin inhibitors on extracellular matrix turnover in isolated human glomeruli. |
2004 |
Transplant. Proc. |
pmid:15110634
|
Wlodarczyk Z et al. |
Lipid metabolism in renal transplant patients receiving tacrolimus/sirolimus combination therapy. |
2005 |
Transplant. Proc. |
pmid:15919489
|
Funayama Y et al. |
Changes in cell adhesion molecules after small bowel transplantation in rats. |
1995 |
Transplant. Proc. |
pmid:7533426
|
Paul AA et al. |
CMV retinitis and the use of FK 506. |
1991 |
Transplant. Proc. |
pmid:1721354
|
Nanni G et al. |
Lack of correlation between serum levels of mycophenolate mofetil and kidney transplant outcome in tacrolimus-based immunosupression. |
2002 |
Transplant. Proc. |
pmid:12270323
|
Pape L et al. |
Long-term stable glomerular filtration rate achieved with tacrolimus in pediatric renal transplantation. |
2002 |
Transplant. Proc. |
pmid:12270367
|
Miyagi M et al. |
Comparison of the therapeutic effects between CsA and FK506 on chronic renal allograft injury and TGF-beta expression. |
2002 |
Transplant. Proc. |
pmid:12176497
|
van Hooff JP et al. |
Benelux experience with a combination of tacrolimus and mycophenolate mofetil: 4-year results. |
2002 |
Transplant. Proc. |
pmid:12176498
|
Gruttadauria S et al. |
Basiliximab in a triple-drug regimen with tacrolimus and steroids in liver transplantation. |
2005 Jul-Aug |
Transplant. Proc. |
pmid:16182762
|
Gojowy D et al. |
High Frequency of Arterial Hypertension in Patients After Liver Transplantation. |
2016 |
Transplant. Proc. |
pmid:27496479
|
Wilusz M et al. |
Effects of Immunosuppressive Drugs on Serum Fatty Acids of Phospholipids Fraction in Renal Transplant Recipients. |
2016 |
Transplant. Proc. |
pmid:27496457
|
Takayama J et al. |
Living related liver transplantation in patients with ABO incompatibility. |
1998 |
Transplant. Proc. |
pmid:9838537
|
Wu MS et al. |
Cyclosporine, but not FK 506 and rapamycin, enhances cell proliferation in mouse medullary thick ascending cultured cells. |
1998 |
Transplant. Proc. |
pmid:9838561
|
Scott JS et al. |
Tacrolimus: a cause of hypertrophic cardiomyopathy in pediatric heart transplant recipients? |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083017
|
Meiser BM et al. |
The efficacy of the combination of tacrolimus and mycophenolate mofetil for prevention of acute myocardial rejection is dependent on routine monitoring of mycophenolic acid trough acid levels. |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083018
|
Platz KP et al. |
Impact of immunosuppression and acute rejection on hepatitis B recurrence. |
1997 Feb-Mar |
Transplant. Proc. |
pmid:9123107
|
Reyes J et al. |
Intestinal transplantation in children: five-year experience. |
1996 |
Transplant. Proc. |
pmid:8908042
|
Okano K et al. |
Ameliorative effect of FK 506 on cold ischemia reperfusion injury of the rat liver. |
1994 |
Transplant. Proc. |
pmid:7520635
|
Endoh M et al. |
Nonmuscle myosin heavy chain and metalloproteinase-2 expression in concordant pulmonary xenografts. |
2000 |
Transplant. Proc. |
pmid:10936397
|
Yoshimura N et al. |
A new immunosuppressive agent, FK506, inhibits the expression of alloantigen-activated suppressor cells as well as the induction of alloreactivity. |
1989 |
Transplant. Proc. |
pmid:2468202
|
McCauley J et al. |
Renal function after conversion from cyclosporine to FK 506 in liver transplant patients. |
1991 |
Transplant. Proc. |
pmid:1721387
|
Citterio F et al. |
Steroid withdrawal from tacrolimus-based therapy in renal transplant patients. |
2002 |
Transplant. Proc. |
pmid:12176545
|
Steinmueller T et al. |
The effect of cyclosporine vs FK 506 on glucose metabolism. |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083504
|
Tsao CI et al. |
Unplanned readmission within 1 year after heart transplantation in Taiwan. |
2010 |
Transplant. Proc. |
pmid:20430212
|
Lee H et al. |
Thymoglobulin Versus Basiliximab Induction Therapy in Low-Risk Kidney Transplant Recipients: A Single-Center Experience. |
2018 |
Transplant. Proc. |
pmid:29880348
|
Fang YH et al. |
AEB-071 versus tacrolimus monotherapy to prevent acute cardiac allograft rejection in the rat: a preliminary report. |
2010 |
Transplant. Proc. |
pmid:20430219
|
Iacona I et al. |
Mycophenolic acid in combination with FK 506: a pharmacokinetic study in piglets after small-bowel transplantation. |
1997 Feb-Mar |
Transplant. Proc. |
pmid:9123489
|
Langer RM et al. |
De novo tumors after kidney transplantation: the Budapest experience. |
2003 |
Transplant. Proc. |
pmid:12826170
|
Masaoka T et al. |
Phase II study of FK 506 for allogeneic bone marrow transplantation. |
1991 |
Transplant. Proc. |
pmid:1721417
|
Tojimbara T et al. |
Cyclosporine and tacrolimus both suppress activation of Kupffer cells in vitro. |
1996 |
Transplant. Proc. |
pmid:8658704
|
Markus PM et al. |
The effect of cyclosporine, rapamycin and FK 506 the survival following allogeneic bone marrow transplantation. |
1991 |
Transplant. Proc. |
pmid:1721418
|
Yuzawa K et al. |
Topical immunosuppression in skin grafting with FK 506 ointment. |
1996 |
Transplant. Proc. |
pmid:8658707
|
White SA et al. |
Randomized trial comparing neoral and tacrolimus immunousuppression for recipients of renal transplants procured from different donor groups. |
2000 |
Transplant. Proc. |
pmid:10812132
|
Chang HR et al. |
Sirolimus addition is beneficial for renal allograft dysfunction due to simultaneous acute rejection episode and calcineurin inhibitor nephrotoxicity. |
2004 |
Transplant. Proc. |
pmid:15621119
|
Calne RY |
The development of immunosuppression: the rapamycin milestone. |
2003 |
Transplant. Proc. |
pmid:12742463
|
Woeste G et al. |
Tacrolimus/mycophenolate mofetil vs cyclosporine A/Azathioprine after simultaneous pancreas and kidney transplantation: five-year results of a randomized study. |
2002 |
Transplant. Proc. |
pmid:12176629
|
Aguirrezabalaga J et al. |
Lipid profiles in liver transplantation in patients receiving tacrolimus or cyclosporin. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267192
|
Shishido S et al. |
Pharmacokinetics of tacrolimus in pediatric renal transplant recipients. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267193
|
Varghese Z et al. |
Oxidizability of low-density lipoproteins from Neoral and tacrolimus-treated renal transplant patients. |
1998 |
Transplant. Proc. |
pmid:9723384
|
Duzova A et al. |
Triple immunosuppression with or without basiliximab in pediatric renal transplantation: acute rejection rates at one year. |
2003 |
Transplant. Proc. |
pmid:14697926
|
Reichenspurner H et al. |
First experience with FK 506 for treatment of chronic pulmonary rejection. |
1995 |
Transplant. Proc. |
pmid:7540775
|
Abu-Elmagd K et al. |
FK 506: a new therapeutic agent for severe recalcitrant psoriasis. |
1991 |
Transplant. Proc. |
pmid:1721449
|
Ueda D et al. |
Influence of FK 506 on renal blood flow. |
1993 |
Transplant. Proc. |
pmid:7689280
|
Ito Y et al. |
Complete replacement of tracheal epithelia by the host promotes spontaneous acceptance of orthotopic tracheal allografts in rats. |
2004 |
Transplant. Proc. |
pmid:15561264
|
Kiji T et al. |
Relationship between immunological rejection and matrix GLA protein in cryopreserved vascular allografts. |
2004 |
Transplant. Proc. |
pmid:15561265
|
Banerjee R et al. |
Coadministration of itraconazole and tacrolimus after thoracic organ transplantation. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267435
|
Mehra MR et al. |
A randomized comparison of an immunosuppressive strategy using tacrolimus and cyclosporine in black heart transplant recipients. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267438
|
Fujimura T et al. |
Cellular surface molecular and cytokine gene expression in rat heart allografts under optimal doses of cyclosporine and FK 506. |
1998 |
Transplant. Proc. |
pmid:9636413
|
Yoshimura N et al. |
Development of a macromolecular prodrug of FK 506: III: In vivo disposition of FK 506-dextran conjugate. |
1998 |
Transplant. Proc. |
pmid:9636415
|
Kacar S et al. |
Low-dose calcineurin inhibitor regimen combined with mammalian target of rapamycin inhibitors preserves kidney functions in renal transplant recipients without allograft nephropathy. |
2010 |
Transplant. Proc. |
pmid:21094806
|
McLaughlin GE et al. |
Effect of aminophylline on urine flow in children with tacrolimus-induced renal insufficiency. |
2000 |
Transplant. Proc. |
pmid:10856596
|
Fung JJ et al. |
Conversion of liver allograft recipients from cyclosporine to FK 506-based immunosuppression: benefits and pitfalls. |
1991 |
Transplant. Proc. |
pmid:1703682
|
Nanmoku K et al. |
Effective and Safe Reduction of Conventional Immunosuppressants Using Everolimus in Maintenance Kidney Transplant Recipients. |
2017 |
Transplant. Proc. |
pmid:28923615
|
Ott R et al. |
Conversion from tacrolimus to Neoral in liver and kidney transplant recipients. |
2001 Nov-Dec |
Transplant. Proc. |
pmid:11750359
|
Kliem V et al. |
Tacrolimus for steroid- and OKT3-resistant rejection in kidney recipients. |
1998 |
Transplant. Proc. |
pmid:9636509
|